Compare OMCL & HYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMCL | HYT |
|---|---|---|
| Founded | 1992 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Finance Companies |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2001 | N/A |
| Metric | OMCL | HYT |
|---|---|---|
| Price | $43.73 | $9.37 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $43.00 | N/A |
| AVG Volume (30 Days) | ★ 497.6K | 443.0K |
| Earning Date | 10-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.61% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $1,177,740,000.00 | N/A |
| Revenue This Year | $8.61 | N/A |
| Revenue Next Year | $3.97 | N/A |
| P/E Ratio | $102.68 | ★ N/A |
| Revenue Growth | ★ 10.67 | N/A |
| 52 Week Low | $22.66 | $8.18 |
| 52 Week High | $47.69 | $9.91 |
| Indicator | OMCL | HYT |
|---|---|---|
| Relative Strength Index (RSI) | 74.57 | 44.01 |
| Support Level | $39.18 | $9.40 |
| Resistance Level | $45.36 | $9.49 |
| Average True Range (ATR) | 1.91 | 0.06 |
| MACD | 0.53 | 0.00 |
| Stochastic Oscillator | 85.53 | 54.62 |
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
BlackRock Corporate High Yield Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income and capital appreciation. The trust's secondary investment objective is to provide shareholders with capital appreciation. It seeks to achieve its objectives by investing in a diversified portfolio of fixed-income securities.